247 related articles for article (PubMed ID: 16822578)
41. Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas.
Conde E; Suarez-Gauthier A; García-García E; Lopez-Rios F; Lopez-Encuentra A; García-Lujan R; Morente M; Sanchez-Verde L; Sanchez-Cespedes M
Hum Pathol; 2007 Sep; 38(9):1351-60. PubMed ID: 17521700
[TBL] [Abstract][Full Text] [Related]
42. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
[TBL] [Abstract][Full Text] [Related]
43. Two novel mutations and a new STK11/LKB1 gene isoform in Peutz-Jeghers patients.
Resta N; Stella A; Susca FC; Di Giacomo M; Forleo G; Miccolis I; Rossini FP; Genuardi M; Piepoli A; Grammatico P; Guanti G
Hum Mutat; 2002 Jul; 20(1):78-9. PubMed ID: 12112668
[TBL] [Abstract][Full Text] [Related]
44. Mutations and deletions of the CBP gene in human lung cancer.
Kishimoto M; Kohno T; Okudela K; Otsuka A; Sasaki H; Tanabe C; Sakiyama T; Hirama C; Kitabayashi I; Minna JD; Takenoshita S; Yokota J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):512-9. PubMed ID: 15701835
[TBL] [Abstract][Full Text] [Related]
45. LKB1 protein expression in neuroendocrine tumors of the lung.
Amin RM; Hiroshima K; Iyoda A; Hoshi K; Honma K; Kuroki M; Kokubo T; Fujisawa T; Miyagi Y; Nakatani Y
Pathol Int; 2008 Feb; 58(2):84-8. PubMed ID: 18199157
[TBL] [Abstract][Full Text] [Related]
46. STK11/LKB1 germline mutations in the first Peutz-Jeghers syndrome patients identified in Slovakia.
Bartosova Z; Zavodna K; Krivulcik T; Usak J; Mlkva I; Kruzliak T; Hromec J; Usakova V; Kopecka I; Veres P; Bartosova Z; Bujalkova M
Neoplasma; 2007; 54(2):101-7. PubMed ID: 17319781
[TBL] [Abstract][Full Text] [Related]
47. LKB1 somatic mutations in sporadic tumors.
Avizienyte E; Loukola A; Roth S; Hemminki A; Tarkkanen M; Salovaara R; Arola J; Bützow R; Husgafvel-Pursiainen K; Kokkola A; Järvinen H; Aaltonen LA
Am J Pathol; 1999 Mar; 154(3):677-81. PubMed ID: 10079245
[TBL] [Abstract][Full Text] [Related]
48. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
49. Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis.
Wei C; Amos CI; Stephens LC; Campos I; Deng JM; Behringer RR; Rashid A; Frazier ML
Cancer Res; 2005 Dec; 65(24):11297-303. PubMed ID: 16357136
[TBL] [Abstract][Full Text] [Related]
50. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
[TBL] [Abstract][Full Text] [Related]
51. Novel microdeletion in the transforming growth factor beta type II receptor gene is associated with giant and large cell variants of nonsmall cell lung carcinoma.
Wang JC; Su CC; Xu JB; Chen LZ; Hu XH; Wang GY; Bao Y; Huang Q; Fu SB; Li P; Lu CQ; Zhang RM; Luo ZW
Genes Chromosomes Cancer; 2007 Feb; 46(2):192-201. PubMed ID: 17117417
[TBL] [Abstract][Full Text] [Related]
52. Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues.
Kojima K; Motoshima H; Tsutsumi A; Igata M; Matsumura T; Kondo T; Kawashima J; Ichinose K; Furukawa N; Inukai K; Katayama S; Goldstein BJ; Nishikawa T; Tsuruzoe K; Araki E
Biochem Biophys Res Commun; 2008 Nov; 376(2):434-8. PubMed ID: 18789895
[TBL] [Abstract][Full Text] [Related]
53. The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity.
Zhang S; Schafer-Hales K; Khuri FR; Zhou W; Vertino PM; Marcus AI
Cancer Res; 2008 Feb; 68(3):740-8. PubMed ID: 18245474
[TBL] [Abstract][Full Text] [Related]
54. Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose.
Jiang W; Zhu Z; Thompson HJ
Mol Carcinog; 2008 Aug; 47(8):616-28. PubMed ID: 18247380
[TBL] [Abstract][Full Text] [Related]
55. Mutational inactivation of aminoacylase-I in a small cell lung cancer cell line.
Cook RM; Franklin WA; Moore MD; Johnson BE; Miller YE
Genes Chromosomes Cancer; 1998 Apr; 21(4):320-5. PubMed ID: 9559343
[TBL] [Abstract][Full Text] [Related]
56. LKB1 catalytically deficient mutants enhance cyclin D1 expression.
Scott KD; Nath-Sain S; Agnew MD; Marignani PA
Cancer Res; 2007 Jun; 67(12):5622-7. PubMed ID: 17575127
[TBL] [Abstract][Full Text] [Related]
57. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.
Bardeesy N; Sinha M; Hezel AF; Signoretti S; Hathaway NA; Sharpless NE; Loda M; Carrasco DR; DePinho RA
Nature; 2002 Sep; 419(6903):162-7. PubMed ID: 12226664
[TBL] [Abstract][Full Text] [Related]
58. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway.
Murase T; Misawa K; Haramizu S; Hase T
Biochem Pharmacol; 2009 Jul; 78(1):78-84. PubMed ID: 19447226
[TBL] [Abstract][Full Text] [Related]
59. Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice.
Thomson DM; Porter BB; Tall JH; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E196-202. PubMed ID: 16926377
[TBL] [Abstract][Full Text] [Related]
60. Ganglioglioma arising in a Peutz-Jeghers patient: a case report with molecular implications.
Resta N; Lauriola L; Puca A; Susca FC; Albanese A; Sabatino G; Di Giacomo MC; Gessi M; Guanti G
Acta Neuropathol; 2006 Jul; 112(1):106-11. PubMed ID: 16733653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
